Cargando…

Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study

AIMS: This study aimed to identify risk factors (patient, healthcare system, and socioeconomic) for mortality after hip fractures and estimate their relative importance. Further, we aimed to elucidate mortality and survival patterns following fractures and the duration of excess mortality. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjærvik, Cato, Gjertsen, Jan-Erik, Stensland, Eva, Saltyte-Benth, Jurate, Soereide, Odd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Editorial Society of Bone & Joint Surgery 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251134/
https://www.ncbi.nlm.nih.gov/pubmed/35775181
http://dx.doi.org/10.1302/0301-620X.104B7.BJJ-2021-1806.R1
_version_ 1784739972257939456
author Kjærvik, Cato
Gjertsen, Jan-Erik
Stensland, Eva
Saltyte-Benth, Jurate
Soereide, Odd
author_facet Kjærvik, Cato
Gjertsen, Jan-Erik
Stensland, Eva
Saltyte-Benth, Jurate
Soereide, Odd
author_sort Kjærvik, Cato
collection PubMed
description AIMS: This study aimed to identify risk factors (patient, healthcare system, and socioeconomic) for mortality after hip fractures and estimate their relative importance. Further, we aimed to elucidate mortality and survival patterns following fractures and the duration of excess mortality. METHODS: Data on 37,394 hip fractures in the Norwegian Hip Fracture Register from January 2014 to December 2018 were linked to data from the Norwegian Patient Registry, Statistics Norway, and characteristics of acute care hospitals. Cox regression analysis was performed to estimate risk factors associated with mortality. The Wald statistic was used to estimate and illustrate relative importance of risk factors, which were categorized in modifiable (healthcare-related) and non-modifiable (patient-related and socioeconomic). We calculated standardized mortality ratios (SMRs) comparing deaths among hip fracture patients to expected deaths in a standardized reference population. RESULTS: Mean age was 80.2 years (SD 11.4) and 67.5% (n = 25,251) were female. Patient factors (male sex, increasing comorbidity (American Society of Anesthesiologists grade and Charlson Comorbidity Index)), socioeconomic factors (low income, low education level, living in a healthcare facility), and healthcare factors (hip fracture volume, availability of orthogeriatric services) were associated with increased mortality. Non-modifiable risk factors were more strongly associated with mortality than modifiable risk factors. The SMR analysis suggested that cumulative excess mortality among hip fracture patients was 16% in the first year and 41% at six years. SMR was 2.48 for the six-year observation period, most pronounced in the first year, and fell from 10.92 in the first month to 3.53 after 12 months and 2.48 after six years. Substantial differences in median survival time were found, particularly for patient-related factors. CONCLUSION: Socioeconomic, patient-, and healthcare-related factors all contributed to excess mortality, and non-modifiable factors had stronger association than modifiable ones. Hip fractures contributed to substantial excess mortality. Apparently small survival differences translate into substantial disparity in median survival time in this elderly population. Cite this article: Bone Joint J 2022;104-B(7):884–893.
format Online
Article
Text
id pubmed-9251134
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Editorial Society of Bone & Joint Surgery
record_format MEDLINE/PubMed
spelling pubmed-92511342022-07-07 Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study Kjærvik, Cato Gjertsen, Jan-Erik Stensland, Eva Saltyte-Benth, Jurate Soereide, Odd Bone Joint J Trauma AIMS: This study aimed to identify risk factors (patient, healthcare system, and socioeconomic) for mortality after hip fractures and estimate their relative importance. Further, we aimed to elucidate mortality and survival patterns following fractures and the duration of excess mortality. METHODS: Data on 37,394 hip fractures in the Norwegian Hip Fracture Register from January 2014 to December 2018 were linked to data from the Norwegian Patient Registry, Statistics Norway, and characteristics of acute care hospitals. Cox regression analysis was performed to estimate risk factors associated with mortality. The Wald statistic was used to estimate and illustrate relative importance of risk factors, which were categorized in modifiable (healthcare-related) and non-modifiable (patient-related and socioeconomic). We calculated standardized mortality ratios (SMRs) comparing deaths among hip fracture patients to expected deaths in a standardized reference population. RESULTS: Mean age was 80.2 years (SD 11.4) and 67.5% (n = 25,251) were female. Patient factors (male sex, increasing comorbidity (American Society of Anesthesiologists grade and Charlson Comorbidity Index)), socioeconomic factors (low income, low education level, living in a healthcare facility), and healthcare factors (hip fracture volume, availability of orthogeriatric services) were associated with increased mortality. Non-modifiable risk factors were more strongly associated with mortality than modifiable risk factors. The SMR analysis suggested that cumulative excess mortality among hip fracture patients was 16% in the first year and 41% at six years. SMR was 2.48 for the six-year observation period, most pronounced in the first year, and fell from 10.92 in the first month to 3.53 after 12 months and 2.48 after six years. Substantial differences in median survival time were found, particularly for patient-related factors. CONCLUSION: Socioeconomic, patient-, and healthcare-related factors all contributed to excess mortality, and non-modifiable factors had stronger association than modifiable ones. Hip fractures contributed to substantial excess mortality. Apparently small survival differences translate into substantial disparity in median survival time in this elderly population. Cite this article: Bone Joint J 2022;104-B(7):884–893. The British Editorial Society of Bone & Joint Surgery 2022-07 2022-07-01 /pmc/articles/PMC9251134/ /pubmed/35775181 http://dx.doi.org/10.1302/0301-620X.104B7.BJJ-2021-1806.R1 Text en © 2022 Author(s) et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Trauma
Kjærvik, Cato
Gjertsen, Jan-Erik
Stensland, Eva
Saltyte-Benth, Jurate
Soereide, Odd
Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study
title Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study
title_full Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study
title_fullStr Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study
title_full_unstemmed Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study
title_short Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018: a linked multiregistry study
title_sort modifiable and non-modifiable risk factors in hip fracture mortality in norway, 2014 to 2018: a linked multiregistry study
topic Trauma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251134/
https://www.ncbi.nlm.nih.gov/pubmed/35775181
http://dx.doi.org/10.1302/0301-620X.104B7.BJJ-2021-1806.R1
work_keys_str_mv AT kjærvikcato modifiableandnonmodifiableriskfactorsinhipfracturemortalityinnorway2014to2018alinkedmultiregistrystudy
AT gjertsenjanerik modifiableandnonmodifiableriskfactorsinhipfracturemortalityinnorway2014to2018alinkedmultiregistrystudy
AT stenslandeva modifiableandnonmodifiableriskfactorsinhipfracturemortalityinnorway2014to2018alinkedmultiregistrystudy
AT saltytebenthjurate modifiableandnonmodifiableriskfactorsinhipfracturemortalityinnorway2014to2018alinkedmultiregistrystudy
AT soereideodd modifiableandnonmodifiableriskfactorsinhipfracturemortalityinnorway2014to2018alinkedmultiregistrystudy